Filtrer vos résultats
- 3
- 3
- 3
- 1
- 2
- 3
- 3
- 2
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
INTEGRIN A5 IS A POOR PROGNOSTIC FACTOR IN PATIENTS WITH GLIOBLASTOMA TREATED BY THE STUPP PROTOCOLNeuro-Oncology, 2019, 21 (3), pp.97. ⟨10.1093/neuonc/noz126.357⟩
Article dans une revue
hal-03598665v1
|
||
|
Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trialAnnals of Oncology, 2020, 31 (4), pp.S660. ⟨10.1016/j.annonc.2020.08.1029⟩
Article dans une revue
hal-03600469v1
|
||
|
RETROSPECTIVE ANALYSIS OF LONG-TERM RESPONSE TO BEVACIZUMAB IN COMBINATION WITH IRINOTECAN FOR RECURRENT GLIOBLASTOMA: IDENTIFICATION OF PROGNOSTIC FACTORSNeuro-Oncology, 2019, 21 (3), pp.98. ⟨10.1093/neuonc/noz126.360⟩
Article dans une revue
hal-03598663v1
|